Nouveauté

Ovarian Cancer - Basics to Mastery

Par : DEAN STRATTON
Offrir maintenant
Ou planifier dans votre panier
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub protégé est :
  • Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
  • Compatible avec une lecture sur liseuses Vivlio
  • Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
  • Non compatible avec un achat hors France métropolitaine
Logo Vivlio, qui est-ce ?

Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement

Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
Google PlayApp Store
  • FormatePub
  • ISBN8232695675
  • EAN9798232695675
  • Date de parution17/11/2025
  • Protection num.Adobe DRM
  • Infos supplémentairesepub
  • ÉditeurHamza elmir

Résumé

From foundational biology through advanced therapeutics, this comprehensive guide clarifies how epithelial, germ cell, and sex cord-stromal tumors differ in origin, behavior, and care. Readers learn risk factors (age, hereditary syndromes such as BRCA1/2 and Lynch), protective strategies (oral contraceptives and risk-reducing salpingo-oophorectomy in appropriate candidates), early symptom patterns (bloating, pelvic pressure, early satiety), evaluation (history, examination, transvaginal ultrasound, judicious tumor markers), why routine screening is not recommended at average risk, and how FIGO staging directs surgery, chemotherapy, targeted therapy, and surveillance.
Step-by-step chapters cover primary cytoreduction versus neoadjuvant pathways, platinum-taxane backbones, PARP inhibitors and anti-angiogenics, survivorship, fertility preservation, palliative integration, and multidisciplinary coordination. Realistic case vignettes, checklists, and flowcharts turn complex decisions into clear actions for trainees, nurses, and busy clinicians.? Evidence maps and algorithms for initial workup, staging, and treatment sequencing? Practical surgical planning: when to attempt complete cytoreduction and when to use neoadjuvant therapy? Genetics made usable: testing pathways, consent language, cascade counseling, and risk reduction? Drug tables linking mechanisms to indications, dosing, toxicities, and monitoring? Recurrence playbook: defining platinum sensitivity, maintenance options, and clinical-trial windows? Communication tools: symptom diaries, shared decisions, survivorship, and end-of-life planning
From foundational biology through advanced therapeutics, this comprehensive guide clarifies how epithelial, germ cell, and sex cord-stromal tumors differ in origin, behavior, and care. Readers learn risk factors (age, hereditary syndromes such as BRCA1/2 and Lynch), protective strategies (oral contraceptives and risk-reducing salpingo-oophorectomy in appropriate candidates), early symptom patterns (bloating, pelvic pressure, early satiety), evaluation (history, examination, transvaginal ultrasound, judicious tumor markers), why routine screening is not recommended at average risk, and how FIGO staging directs surgery, chemotherapy, targeted therapy, and surveillance.
Step-by-step chapters cover primary cytoreduction versus neoadjuvant pathways, platinum-taxane backbones, PARP inhibitors and anti-angiogenics, survivorship, fertility preservation, palliative integration, and multidisciplinary coordination. Realistic case vignettes, checklists, and flowcharts turn complex decisions into clear actions for trainees, nurses, and busy clinicians.? Evidence maps and algorithms for initial workup, staging, and treatment sequencing? Practical surgical planning: when to attempt complete cytoreduction and when to use neoadjuvant therapy? Genetics made usable: testing pathways, consent language, cascade counseling, and risk reduction? Drug tables linking mechanisms to indications, dosing, toxicities, and monitoring? Recurrence playbook: defining platinum sensitivity, maintenance options, and clinical-trial windows? Communication tools: symptom diaries, shared decisions, survivorship, and end-of-life planning